NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Return on Equity [ROE] (2019 - 2026)

Updated

NextCure (NXTC) recorded Return on Equity [ROE] of -990.05% in Q3 2026, down 607.92 percentage points from -382.13% a year earlier and down 531.34 percentage points from the prior quarter.

Analysis

NextCure (NXTC) Return on Equity [ROE] (2019 - 2026) Analysis & Trends

For FY2025, NextCure reported Return on Equity [ROE] of -111.19%, down 49.57 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for five straight years, with a five-year change of -99.55 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -61.62% in FY2024 (-18.03 pp), -43.59% in FY2023 (-5.89 pp), -37.70% in FY2022 (-10.82 pp) and -26.88% in FY2021 (-15.23 pp).
  • The Q3 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q2 2019.
  • On a year-over-year basis, Return on Equity [ROE] has declined for 23 consecutive quarters, with an average year-over-year change of -210.52 percentage points over the last eight quarters.
  • Across the past five years, year-over-year drop in Return on Equity [ROE] ran from 11.42 percentage points in Q2 2022 to 607.92 percentage points in Q3 2026.
  • Per Business Quant, the preceding three quarters came in at -458.71% (Q2 2026), -327.81% (Q1 2026) and -348.95% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 19.33%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 5.63%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 21.60%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 72.13%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -31.17%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.66%
10 NextCure 29.30 Mn -71.08 Mn - -990.05%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -990.05%
Jun 30, 2026 -458.71%
Mar 31, 2026 -327.81%
Dec 31, 2025 -348.95%
Sep 30, 2025 -382.13%
Jun 30, 2025 -244.68%
Mar 31, 2025 -153.46%
Dec 31, 2024 -140.62%
Sep 30, 2024 -130.66%
Jun 30, 2024 -116.87%
Mar 31, 2024 -103.51%
Dec 31, 2023 -90.35%
Sep 30, 2023 -92.82%
Jun 30, 2023 -87.42%
Mar 31, 2023 -79.57%
Dec 31, 2022 -77.19%
Sep 30, 2022 -40.36%
Jun 30, 2022 -36.66%
Mar 31, 2022 -33.91%
Dec 31, 2021 -29.41%
API Access

NextCure Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NXTC&period=max&api_key=YOUR_API_KEY